Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Pure Storage (PSTG) Q4 Earnings and Revenues Beat Estimates
Pure Storage (PSTG) Q4 Earnings and Revenues Beat Estimates

Pure Storage (PSTG) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.45 per share a year ago. These

RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates
RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates

RxSight, Inc. (RXST) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.03 per share a year ago. These figures

Nutanix (NTNX) Q2 Earnings and Revenues Surpass Estimates
Nutanix (NTNX) Q2 Earnings and Revenues Surpass Estimates

Nutanix (NTNX) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.56 per share a year ago. These figures

IonQ, Inc. (IONQ) Surpasses Q4 Earnings and Revenue Estimates
IonQ, Inc. (IONQ) Surpasses Q4 Earnings and Revenue Estimates

IonQ, Inc. (IONQ) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of a loss of $0.48 per share. This compares to a loss of $0.93 per share a year ago. These

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates

Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.06 per share a year

MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates

MiMedx (MDXG) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.07 per share a year ago. These figures are

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates

Mirum Pharmaceuticals, Inc. (MIRM) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of $0.02. This compares to a loss of $0.49 per share a year ago. These

McGrath (MGRC) Q4 Earnings and Revenues Top Estimates
McGrath (MGRC) Q4 Earnings and Revenues Top Estimates

McGrath (MGRC) came out with quarterly earnings of $2.02 per share, beating the Zacks Consensus Estimate of $1.74 per share. This compares to earnings of $1.58 per share a year ago. These figures

Montrose Environmental (MEG) Beats Q4 Earnings and Revenue Estimates
Montrose Environmental (MEG) Beats Q4 Earnings and Revenue Estimates

Montrose Environmental (MEG) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.29 per share a year ago

Chord Energy Corporation (CHRD) Q4 Earnings Top Estimates
Chord Energy Corporation (CHRD) Q4 Earnings Top Estimates

Chord Energy Corporation (CHRD) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.17 per share. This compares to earnings of $3.49 per share a year ago

Enovix Corporation (ENVX) Reports Q4 Loss, Beats Revenue Estimates
Enovix Corporation (ENVX) Reports Q4 Loss, Beats Revenue Estimates

Enovix Corporation (ENVX) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.11 per share a year ago. These

BJ's Restaurants (BJRI) Q4 Earnings and Revenues Surpass Estimates
BJ's Restaurants (BJRI) Q4 Earnings and Revenues Surpass Estimates

BJ's Restaurants (BJRI) came out with quarterly earnings of $0.66 per share, beating the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.47 per share a year ago. These

Churchill Downs (CHDN) Q4 Earnings and Revenues Beat Estimates
Churchill Downs (CHDN) Q4 Earnings and Revenues Beat Estimates

Churchill Downs (CHDN) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.92 per share a year ago. These

Salesforce (CRM) Beats Q4 Earnings and Revenue Estimates
Salesforce (CRM) Beats Q4 Earnings and Revenue Estimates

Salesforce (CRM) came out with quarterly earnings of $3.81 per share, beating the Zacks Consensus Estimate of $3.03 per share. This compares to earnings of $2.78 per share a year ago. These figures

Amerisafe (AMSF) Q4 Earnings Miss Estimates
Amerisafe (AMSF) Q4 Earnings Miss Estimates

Amerisafe (AMSF) came out with quarterly earnings of $0.51 per share, missing the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.67 per share a year ago. These figures

Alector (ALEC) Reports Q4 Loss, Beats Revenue Estimates
Alector (ALEC) Reports Q4 Loss, Beats Revenue Estimates

Alector (ALEC) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.02 per share a year ago. These figures are

ARKO Corp. (ARKO) Reports Break-Even Earnings for Q4
ARKO Corp. (ARKO) Reports Break-Even Earnings for Q4

ARKO Corp. (ARKO) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.03 per share a year ago. These figures are

Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates
Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates

Acadia Pharmaceuticals (ACAD) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.17 per share a year ago

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates
Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Arcutis Biotherapeutics, Inc. (ARQT) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to a loss of $0.09 per share a year

Agilent Technologies (A) Lags Q1 Earnings and Revenue Estimates
Agilent Technologies (A) Lags Q1 Earnings and Revenue Estimates

Agilent Technologies (A) came out with quarterly earnings of $1.36 per share, missing the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.31 per share a year ago. These

Brian's Big Idea - No Zacks Rank But On My Radar
Brian's Big Idea - No Zacks Rank But On My Radar

We get a lot of emails from people that want to understand why some stocks have a Zacks Rank and why some do not.  The answer is really quite simple, there needs to be equity research submitted to

3 Silver Mining Stocks That Could Keep Surging: https://staticx-tuner.zacks.com/images/articles/main/db/143466.webp
3 Silver Mining Stocks That Could Keep Surging

Along with gold, silver prices have skyrocketed to new all-time highs, with these two historic safe-haven metals having one of the strongest long-term relationships in global markets.

Ultimately,

Tempus AI Sold Off After a Beat—But the Rebound Case Is Building
Tempus AI Sold Off After a Beat—But the Rebound Case Is Building

Tempus AI (NASDAQ: TEM) appears to be a smart buy for tech traders as it is a leading provider of AI-enabled services and infrastructure for healthcare, and its stock is set up to rebound

RH (RH) Stock Slides as Market Rises: Facts to Know Before You Trade
RH (RH) Stock Slides as Market Rises: Facts to Know Before You Trade

RH (RH) ended the recent trading session at $184.01, demonstrating a -3.36% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.81%

TXO Partners LP (TXO) Stock Drops Despite Market Gains: Important Facts to Note
TXO Partners LP (TXO) Stock Drops Despite Market Gains: Important Facts to Note

TXO Partners LP (TXO) closed the most recent trading day at $12.54, moving -1.03% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.81%. Meanwhile